新天地：获得药品注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug registration certificate of Vildagliptin tablets, which are indicated for the treatment of type 2 diabetes [1] Group 1 - The drug's generic name is Vildagliptin tablets [1] - The main component, Vildagliptin, is a selective Dipeptidyl Peptidase-4 (DPP-4) inhibitor [1]